Analysis of Donor-Type Chimerism in Lineage-Specific Cell Populations After Allogeneic Myeloablative and Nonmyeloablative Stem Cell Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Evaluation of Immunomodulatory Treatment Based on Conventional and Lineage-Specific Chimerism Analysis in Patients With Myeloid Malignancies After Myeloablative Allogeneic Hematopoietic Cell Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Haematologica
Hematology
2016English

Chimerism Monitoring Following Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2007English

Monthly Prospective Analysis of Hematopoietic Chimerism After Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2003English

Donor Chimerism in Patients With Primary Immunodeficiency After Allogeneic Hematopoietic Stem Cells Transplantation

Oncogematologiya
OncologyHematology
2018English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

Cerebrospinal Fluid Chimerism Analysis in Patients With Neurological Symptoms After Allogeneic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2015English

Kinetics of Dendritic Cell Chimerism and T Cell Chimerism in Allogeneic Hematopoietic Stem Cell Recipients

Bone Marrow Transplantation
TransplantationHematology
2005English

Evaluation of Chimerism Dynamics After Allogeneic Hematopoietic Stem Cell Transplantation in Children With Non-Malignant Diseases.

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy